Mechanism of antimitogenic action of vitamin D in human colon carcinoma cells: Relevance for suppression of epidermal growth factor-stimulated cell growth

Oncology Research

Volumn 11, Issue 2, 1999, Pages 77-84

  Tong, Wei Min ^a   Hofer, Harald ^a   Ellinger, Adolf ^a   Peterlik, Meinrad ^a,b   Cross, Heide S ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Department of General and Experimental Pathology ^*  (Austria)

Author keywords

1 ,25 dihydroxyvitamin D3; Caco 2 cells; Colorectal cancer; Cyclin D1; Epidermal growth factor receptor; Primary cultures

Indexed keywords

CALCITRIOL; CALCIUM CHANNEL STIMULATING AGENT; CYCLIN D1; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR;

ARTICLE; CELL CULTURE; CELL DIVISION; CELL STRAIN CACO 2; COLON TUMOR; DRUG EFFECT; HUMAN; METABOLISM;

CACO-2 CELLS; CALCITRIOL; CALCIUM CHANNEL AGONISTS; CELL DIVISION; COLONIC NEOPLASMS; CYCLIN D1; EPIDERMAL GROWTH FACTOR; HUMANS; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR CELLS, CULTURED;

EID: 0032612034     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. 3 in HL60 cells. Cancer Res. 56:264-267; 1996.
2. 3. Endocrinology 136:20-26; 1995.
3. 3 on endometrial carcinoma cell lines. J. Obstet. Gynaecol. Res. 22:529-539; 1996.
4. Zugmaier, G.; Jager, R.; Grage, B.; Gottardis, M. M.; Havemann, K.; Knabbe, C. Growth-inhibitory effects of vitamin D analogues and retinoids on human pancreatic cancer cells. Br. J. Cancer 73: 1341-1346; 1996.
5. Cross, H. S.; Pavelka, M.; Slavik, J.; Peterlik, M. Growth control of human colon cancer cells by vitamin D and calcium in vitro. J. Natl. Cancer Inst. 84:1355-1357; 1992.
6. Cross, H. S.; Farsoudi, K. H.; Peterlik, M. Growth inhibition of human colon adenocarcinoma-derived Caco-2 cells by 1,25-dihydroxyvitamin D3 and two synthetic analogs: Relation to in vitro hypercalcemic potential. Naunyn Schmiedebergs Arch. Pharmacol. 347:105-110; 1993.
7. 3 analogs: Structure-function relationships. J. Pharmacol. Exp. Ther. 275:1254-1260; 1995.
8. 3-1α-hydroxylase activity and regulation of side-chain metabolism. J. Steroid Biochem. Mol. Biol. 62:21-28; 1997.
9. Cross, H. S.; Bajna, E.; Bises, G.; Genser, D.; Kállay, E.; Pötzi, R.; Wenzl, E.; Wrba, F.; Roka, R.; Peterlik, M. Vitamin D receptor and cytokeratin expression may be progression indicators in human colon cancer. Anticancer Res. 16:2333-2338; 1996.
10. 3/VDR system of human colonic epithelial cells: Upregulation during tumor progression. In: Norman, A. W.; Bouillon, R.; Thomasset, M., eds. Vitamin D: Chemistry, biology and clinical applications of the steroid hormone. University of California Riverside Press; 1997:495-496.
11. Ribbon, K. A.; Howarth, G. S.; Davey, K. B.; George-Nascimento, C.; Read, L. C. Subcutaneous but not intraluminal epidermal growth factor stimulates colonic growth in normal adult rats. Growth Factors 10:153-162; 1994.
12. Hidalgo, I.; Kato, A.; Borchardt, R. T. Binding of epidermal growth factor by human colon carcinoma Caco-2 cell monolayers. Biochem. Biophys. Res. Commun. 160:317-324; 1989.
13. Cross, H. S.; Quaroni, A. Inhibition of sucrase-isomaltase expression by EGF in the human colon adenocarcinoma cells Caco-2. Am. J. Physiol. 261:C1173-C1183; 1991.
14. Bishop, W. P.; Wen J. T. Regulation of Caco-2 cell proliferation by basolateral membrane epidermal growth factor receptors. Am. J. Physiol. 267:G892-G900; 1994.
15. Radinsky, R.; Risin, S.; Fan, D.; Dong, Z. Y.; Bielenberg, D.; Bucana, C. D.; Fidler, I. J. Level and function of EGFR predict the metastatic potential of human colon carcinoma cells. Clin. Cancer Res. 1:19-31; 1995.
16. Gross, M. E.; Zorbas, M. A.; Daniels, Y. J.; Garcia, R.; Gallick, G. E.; Olive, M.; Brattain, M. G.; Boman, B. M.; Yeoman, L. C. Cellular growth response to epidermal growth factor in colon carcinoma cells with an amplified epidermal growth factor receptor derived from a familial adenomatous polyposis patient. Cancer Res. 51:1452-1459; 1991.
17. 3 is mediated by mutual modulation of receptor expression. Eur. J. Cancer 34:2119-2125; 1998.
18. Hulla, W.; Kállay, E.; Krugluger, W.; Peterlik, M.; Cross, H. S. Growth control of human colon adenocarcinoma-derived Caco-2 cells by vitamin D compounds and extracellular calcium in vitro: Relation to c-myc oncogene and vitamin D receptor expression. Int. J. Cancer 62:711-716; 1995.
19. Wu, X.; Fan, Z.; Masui, H.; Rosen N.; Mendelsohn, J. Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in ahuman colorectal carcinoma cell line and its delay by insulin. J. Clin. Invest. 95:1897-1905; 1995.
20. Kawa, S.; Nikaido, T.; Aoki, Y.; Zhai, Y.; Kumagai, T.; Furihata, K.; Fujii, S.; Kiyosawa, K. Vitamin D analogues up-regulate p21 and p27 during growth inhibition of pancreatic cancer cell lines. Br. J. Cancer 76:884-889; 1997.
21. Ravitz, M. J.; Yan, S.; Dolce, C.; Kinnburgh, A. J.; Wenner, C. E. Differential regulation of p27 and cyclin D1 by TGF-beta and EGF in C3H 10T1/2 mouse fibroblasts. J. Cell Physiol. 168:510-520; 1996.
22. Arber, N.; Hinshoosh, H.; Moss, S. F.; Sutter, T.; Zhang, Y.; Begg, M.; Wang, S.; Weinstein, B.; Holt, P. R. Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis. Gastroenterology 110:669-674; 1996.
23. Zhang, T.; Nanney, L. B.; Luongo, C.; Lamps, L.; Heppner, K. J.; Dubois, R. N.; Beauchamp, R. D. Concurrent overexpression of cyclin D1 and Cdk4 in intestinal adenomas from multiple intestinal neoplasia (Min) mice and human familial adenomatous polyposis patients. Cancer Res. 57:169-175; 1997.
24. Tong, W.-M.; Bises, G.; Sheinin, Y.; Ellinger, A.; Genser, D.; Pötzi, R.; Wrba, F, Wenzl, E.; Roka, R.; Ncuhold, N.; Peterlik, M.; Cross, H. S. Establishment of primary cultures from human colonic tissue during tumor progression: Vitamin-D responses and vitamin D-receptor expression. Int. J. Cancer 75:467-472; 1998.
25. Tong, W.-M.; Ellinger, A.; Sheinin, Y.; Cross, H. S. Epidermal growth factor receptor expression in primary cultured human colorectal carcinoma cells. Br. J. Cancer 77:1792-1798; 1998.
26. Cross, H. S.; Hulla, W.; Tong, W.-M.; Peterlik, M. Growth regulation of human colon adenocarcinoma-derived cells by calcium, vitamin D and epidermal growth factor. J. Nutr. 125:2004S-2008S; 1995.
27. Schwanz, B.; Avivi, C.; Lamprecht, S. A. Isolation and characterization of normal and neoplastic colonic epithelial cell populations. Gastroenterology 100:692-702; 1991.
28. Evers, B. M.; Ko, T. C.; Li, J.; Thompson, E. A. Cell cycle protein suppression and p21 induction in differentiating Caco-2 cells. Am. J. Physiol. 271:G722-G727; 1996.
29. 3 increases epidermal growth factor receptor gene expression in BT-20 breast carcinoma cells. Biochem. Biophys. Res. Commun. 176:1-6; 1991.
30. 3 in human breast cancer cells. Cancer Res. 48:2734-2739; 1988.
31. Femandez-Pol, J. A. Modulation of EGF receptor protooncogene expression by growth factors and hormones in human breast carcinoma cells. Crit. Rev. Oncogen. 2:173-185; 1991.
32. Bartkova, J.; Lukas, J.; Strauss, M.; Bartek, J. The PRAD-1/cyclin D1 oncogene product accumulates aberrantly in a subset of colorectal carcinomas. Int. J. Cancer 58:568-573; 1994.
33. Bates, S.; Peters, G. Cyclin D1 as a cellular proto-oncogene. Semin. Cancer Biol. 6:73-82; 1995.
34. Arber, N.; Doki, Y.; Ban, E. K.-H.; Sgambato, A.; Zhou, P.; Kim, N.-H.; Delohery, T.; Klein, M.G.; Holt, P. R.; Weinstein, I. B. Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells. Cancer Res. 57:1569-1574; 1997.
35. 3 and its analogs on human colon adenocarcinoma cells (Caco-2): Influence of extracellular calcium. Biochem. Biophys. Res. Commun. 179:57-62; 1991.